Maeda et al. [30] showed that SLE CD4+/CD8+ decreased, and human leukocytes expressed the significantly associated antigen HLA-DR through CD8+ T cells, suggesting that the CD4+/CD8+ ratio may be an indicator to assess the treatment efficacy in some SLE patients. This evidence concerns the gene CD4 and systemic lupus erythematosus.